Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Transmembrane protein 255B (TMEM255B) is a member of the transmembrane protein family, encoded by the human gene TMEM255B (NCBI Gene ID: 348013). The protein is predicted to be located in cellular membranes, but its specific localization, molecular function, and role in physiological or pathological processes remain poorly characterized. It is listed in functional genomics and disease association datasets, suggesting wide expression across human tissues and potential relevance to cellular processes, but there is currently no direct experimental evidence implicating TMEM255B in major signaling pathways, disease mechanisms, or as a therapeutic target. Extensive gene expression and association data exist, yet the lack of mechanistic studies means TMEM255B is not considered a validated therapeutic target, nor are there known interacting drugs or established biomarkers at this time.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Transmembrane protein 255B (TMEM255B).